Inflammatory mediators and enzymes

Inflammatory mediators and enzymes represent a broad functional category of molecules that orchestrate the body's response to injury, infection, and tissue stress. This group includes signaling proteins such as cytokines (e.g., TNF, IL-1, IL-6) and chemokines, as well as enzymes like cyclooxygenases (COX) and lipoxygenases (LOX) that synthesize lipid-derived mediators like prostaglandins and leukotrienes (StatPearls, 2023). While these factors are essential for host defense and wound healing, their chronic overproduction or dysregulation is a primary driver of various pathologies, including rheumatoid arthritis, asthma, and atherosclerosis (Nature Reviews Drug Discovery, 2017). Therapeutic strategies often focus on specific members of this class, such as using nonsteroidal anti-inflammatory drugs (NSAIDs) to inhibit COX enzymes or biologics to neutralize specific cytokines like TNF-alpha (PubMed, 2021). Because this term encompasses hundreds of distinct proteins and small molecules rather than a single druggable entity, it is considered a descriptive classification used in clinical and pathological contexts rather than a specific therapeutic target (NIH, 2022).

Other names

Pro-inflammatory mediatorsInflammatory factorsInflammatory signaling moleculesInflammatory markers

Drugs targeting these entities typically act through the inhibition of enzymatic activity (e.g., COX-1/2 inhibition), the neutralization of circulating cytokines (e.g., TNF-alpha monoclonal antibodies), or the antagonism of specific cell-surface receptors to dampen the inflammatory cascade (StatPearls, 2023).